Future opportunities in preventing ototoxicity: Caffeic acid phenethyl ester may be a candidate (review)

Molecular Medicine Reports

Volumn 12, Issue 3, 2015, Pages 3231-3235

  Akyol, Sumeyya ^a   Isik, Bunyamin ^b   Altuntas, Aynur ^c   Erden, Gonul ^b   Cakmak, Ozlem ^d   Kurşunlu, S Fatih ^e   Adam, Bahattin ^f   Akyol, Omer ^b,c  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Council of Forensic Medicine ^*  (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e ADNAN MENDERES UNIVERSITY   (Turkey)

^f SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

Antioxidant; Caffeic acid phenethyl ester; Ear; Ototoxicity; Protection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CAFFEIC ACID PHENETHYL ESTER; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; CAFFEIC ACID DERIVATIVE; PHENETHYL ALCOHOL; PROPOLIS;

ANTIOXIDANT ACTIVITY; CHEMICAL STRUCTURE; DRUG EFFECT; DRUG INDUCED DISEASE; HUMAN; IN VIVO STUDY; MYRINGOSCLEROSIS; OTOTOXICITY; OXIDATIVE STRESS; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; OTITIS MEDIA;

APIS MELLIFERA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CAFFEIC ACIDS; HUMANS; MYRINGOSCLEROSIS; OTITIS MEDIA; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; PROPOLIS;

EID: 84935480925     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3785     Document Type: Review

References (35)

1. Koltuksuz U, Ozen S, Uz E, et al: Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. J Pediatr Surg 34:1458-1462, 1999.
2. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralik H and Akyol O: The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg 16:458-463, 1999.
3. Ozyurt H, Söʇüt S, Yildirim Z, et al: Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta 339:65-75, 2004.
4. Iraz M, Ozerol E, Gulec M, et al: Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct 24:357-361, 2006.
5. Orban Z, Mitsiades N, Burke TR Jr, Tsokos M and Chrousos GP: Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation 7:99-105, 2000.
6. Natarajan K, Singh S, Burke TR Jr, Grunberger D and Aggarwal BB: Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappaB. Proc Natl Acad Sci USA 93:9090-9095, 1996.
7. Huang Q and Tang J: Age-related hearing loss or presbycusis. Eur Arch Otorhinolaryngol 267:1179-1191, 2010.
8. Sha SH, Taylor R, Forge A and Schacht J: Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 155:1-8, 2001.
9. Akyol S, Ozturk G, Ginis Z, Armutcu F, Yigitoglu MR and Akyol O: In vivo and in vitro antineoplastic actions of caffeic acid phenethyl ester (CAPE): Therapeutic perspectives. Nutr Cancer 65:515-526, 2013.
10. Ozturk G, Ginis Z, Akyol S, Erden G, Gurel A and Akyol O: The anticancer mechanism of caffeic acid phenethyl ester (CAPE): Review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci 16:2064-2068, 2012.
11. Akyol S, Ginis Z, Armutcu F, Ozturk G, Yigitoglu MR and Akyol O: The potential usage of caffeic acid phenethyl ester (CAPE) against chemotherapy-induced and radiotherapy-induced toxicity. Cell Biochem Funct 30:438-443, 2012.
12. Khalil MI and Sulaiman SA: The potential role of honey and its polyphenols in preventing heart diseases: a review. Afr J Tradit Complement Altern Med 7:315-321, 2010.
13. Kizilay A, Kalcioglu MT, Ozerol E, et al: Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats. J Chemother 16:381-387, 2004.
14. Rizzi MD and Hirose K: Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 15:352-357, 2007.
15. Poirrier AL, Pincemail J, Van Den Ackerveken P, Lefebvre PP and Malgrange B: Oxidative stress in the cochlea: An update. Curr Med Chem 17:3591-3604, 2010.
16. Sanli A, Aydin S, Sarisoy ZA, Paksoy M, Ayduran E and Erdivanli OC: The protective effect of dexamethasone and lactate against cisplatin-induced ototoxicity. Turk J Med Sci 41:467-474, 2011.
17. van den Berg JH, Beijnen JH, Balm AJ and Schellens JH: Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev 32:390-397, 2006.
18. Yorgason JG, Luxford W and Kalinec F: In vitro and in vivo models of drug ototoxicity: Studying the mechanisms of a clinical problem. Expert Opin Drug Metab Toxicol 7:1521-1534, 2011.
19. Rybak LP and Whitworth CA: Ototoxicity: Therapeutic opportunities. Drug Discov Today 10:1313-1321, 2005.
20. Bakir S, Ozbay M, Gun R, et al: The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity. Am J Otolaryngol 34:16-21, 2013.
21. Sakallioglu O, Yalcin S, Ozel HB, Colakoglu N and Alpay HC: Prenatally exposure to exogenous glucocorticoids and stress may affect the inner ear. Kulak Burun Bogaz Ihtis Derg 23:104-111, 2013.
22. Barrett TQ, Kristiansen LH and Ovesen T: NF-kappaB in cultivated middle ear epithelium. Int J Pediatr Otorhinolaryngol 67:895-903, 2003.
23. Yellon RF, Leonard G, Marucha PT, et al: Characterization of cytokines present in middle ear effusions. Laryngoscope 101:165-169, 1991.
24. Rose AS, Prazma J, Randell SH, Baggett HC, Lane AP and Pillsbury HC: Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion. Otolaryngol Head Neck Surg 116:308-316, 1997.
25. Li W, Lin J, Adams GL and Juhn SK: Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1beta and TNF-alpha. Int J Pediatr Otorhinolaryngol 55:91-98, 2000.
26. Watanabe K, Tomiyama S, Jinnouchi K, Pawankar R and Yagi T: Expression of inducible nitric oxide synthase in the cochlea following immune response in the endolymphatic sac of guinea pigs. ORL J Otorhinolaryngol Relat Spec 63:155-159, 2001.
27. Wright DT, Fischer BM, Li C, Rochelle LG, Akley NJ and Adler KB: Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism. Am J Physiol 271:L854-L861, 1996.
28. Song JJ, Cho JG, Hwang SJ, Cho CG, Park SW and Chae SW: Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells. Acta Otolaryngol 128:1303-1307, 2008.
29. Shin KM, Kim IT, Park YM, et al: Anti-inflammatory effect of caffeic acid methyl ester and its mode of action through the inhibition of prostaglandin E2, nitric oxide and tumor necrosis factor-alpha production. Biochem Pharmacol 68:2327-2336, 2004.
30. Kopp EB and Ghosh S: NF-kappaB and rel proteins in innate immunity. Adv Immunol 58:1-27, 1995.
31. Song JJ, Lim HW, Kim K, Kim KM, Cho S and Chae SW: Effect of caffeic acid phenethyl ester (CAPE) on H2O2 induced oxidative and inflammatory responses in human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol 76:675-679, 2012.
32. Mattsson C, Marklund SL and Hellstrom S: Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106:513-518, 1997.
33. Mattsson C and Hellstrom S: Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254:425-429, 1997.
34. Felding JU, Rasmussen JB and Lildholdt T: Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest Suppl 186:31-41, 1987.
35. Song JJ, Kwon SK, Cho CG and Park SW: The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 71:1287-1291, 2007.